News
Tag: Financial & Investor News
-
Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019
SEATTLE, Wash. and VANCOUVER, British Columbia, May 7, 2019 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will report its first quarter 2019 financial results on Wednesday, May 15, 2019. Company management will host a conference…
-
Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019
SEATTLE, Wash. and VANCOUVER, British Columbia, April 3, 2019 – – Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that Rick Stewart, Chairman and Chief Executive Officer, will present at HC Wainwright Global Life Sciences Conference being held at…
-
Achieve Life Sciences to Present at Oppenheimer’s 29th Annual Healthcare Conference on March 20, 2019
SEATTLE, Wash. and VANCOUVER, British Columbia, March 18, 2019 – – Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that Rick Stewart, Chairman and Chief Executive Officer, will present at Oppenheimer’s 29th Annual Healthcare Conference in New York on…
-
Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
SEATTLE, Wash and VANCOUVER, British Columbia, March 14, 2019 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided an update on the cytisinicline clinical development program and announced fourth quarter and year-end 2018 financial results. Recent Highlights. Completion of…
-
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019
SEATTLE, Wash. and VANCOUVER, British Columbia, March 5, 2019 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will report its fourth quarter and year-end 2018 financial results on Thursday, March 14, 2019. Company management will host…